We previously reported a strong positive association between vasectomy
and the risk of prostatic cancer that arose in multiple comparisons m
ade within data collected from 1976 to 1988 in an ongoing hospital-bas
ed surveillance study of many exposures and diseases. We have reassess
ed this association with data collected in the surveillance study duri
ng 1988-1992 from a new set of patients (355 cases of prostatic cancer
and 2,048 controls with nonmalignant conditions). Because some studie
s have reported increased relative risks of lung cancer and testicular
cancer in vasectomized men, we also used the surveillance database (4
,126 men with various cancers, 7,027 men with nonmalignant conditions)
to assess the relation of vasectomy to the risk of these and other ca
ncers. In the newly collected data, the multivariate relative risk est
imate for prostatic cancer in vasectomized men was 1.2 (95% confidence
interval (CI) 0.6-2.7). For lung cancer and testicular cancer, the re
lative risk estimates were 1.3 (95% CI 0.8-2.1) and 0.8 (95% CI 0.4-1.
9), respectively; for lung cancer occurring greater than or equal to 1
5 years after vasectomy, the relative risk estimate was 1.9 but it was
not statistically significant (95% CI 0.7-5.0). For pancreatic cancer
, the relative risk estimate was 1.8 (95% CI 1.0-3.1). For each of the
other cancers considered-malignant melanoma, large bowel cancer, blad
der cancer, kidney cancer, lymphoma, leukemia, and other cancers-the r
elative risk estimate was 1.3 or less and compatible with a value of 1
.0. The present data provide little support for an association of vase
ctomy with the risk of prostatic cancer or other cancers. In addition,
the data from two sets of cases of prostatic cancer and controls inte
rviewed consecutively illustrate that increased relative risks detecte
d in screening for statistically significant associations may tend to
have an upward bias and to be lower in subsequent data.